Ortho Evra is a contraceptive patch worn by women to accomplish the same contraceptive goals as regular birth control pills. Unlike traditional birth control pills, the Ortho Evra patch is applied to the skin and worn continuously.
Like birth control pills, the Ortho Evra patch increases the levels of estrogen and progestin hormones to prevent ovulation. The Ortho Evra patch is worn continuously for three weeks, and then the user wears no patch for the fourth week. However, the Ortho Evra patch can be dangerous because it exposes the user to 60% more estrogen than traditional birth control pills.
This constant application of the patch creates a steady level of hormones in the bloodstream, unlike having a high amount of hormones for a short period of time as with traditional birth control pills.
The FDA approved the Ortho Evra patch in 2001 and it was released to the public in 2002. Since then, over 5 million women have used it worldwide. The Ortho Evra patch exposes users to increased risks of:
- Blood Clots
- Heart Attacks
- Myocardial Infarction
- Deep Vein Thrombosis
- Pulmonary Embolism
Currently, there are numerous lawsuits being filed against the manufacturers of the Ortho Evra patch, Ortho McNeil, a subsidiary of Johnson & Johnson. If you or a loved one has suffered any of these medical problems from the use of the Ortho Evra patch, contact DeMayo Law Offices, L.L.P. ® today to schedule your free initial consultation.